These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34537988)

  • 1. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
    Ginès P; Castera L; Lammert F; Graupera I; Serra-Burriel M; Allen AM; Wong VW; Hartmann P; Thiele M; Caballeria L; de Knegt RJ; Grgurevic I; Augustin S; Tsochatzis EA; Schattenberg JM; Guha IN; Martini A; Morillas RM; Garcia-Retortillo M; de Koning HJ; Fabrellas N; Pich J; Ma AT; Diaz MA; Roulot D; Newsome PN; Manns M; Kamath PS; Krag A;
    Hepatology; 2022 Jan; 75(1):219-228. PubMed ID: 34537988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
    Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
    Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A health technology assessment of transient elastography in adult liver disease.
    Steadman R; Myers RP; Leggett L; Lorenzetti D; Noseworthy T; Rose S; Sutherland L; Clement F
    Can J Gastroenterol; 2013 Mar; 27(3):149-58. PubMed ID: 23516679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS.
    Castro PCS; Alberton HCP; Pedroso MLA; Morsoletto DBG; Pissaia Junior A; Ivantes CAP
    Arq Gastroenterol; 2019; 56(3):256-260. PubMed ID: 31633721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis.
    Tapper EB; Afdhal NH
    Curr Opin Gastroenterol; 2015 May; 31(3):192-8. PubMed ID: 25730177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT
    Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New non-invasive tool for assessment of liver fibrosis: transient elastography].
    Horváth G
    Orv Hetil; 2011 May; 152(22):860-5. PubMed ID: 21565752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.
    Sporea I; Sirli RL; Deleanu A; Popescu A; Focsa M; Danila M; Tudora A
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S46-52. PubMed ID: 20603783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.
    Obara N; Ueno Y; Fukushima K; Nakagome Y; Kakazu E; Kimura O; Wakui Y; Kido O; Ninomiya M; Kogure T; Inoue J; Kondo Y; Shiina M; Iwasaki T; Yamamoto T; Shimosegawa T
    J Gastroenterol; 2008; 43(9):720-8. PubMed ID: 18807134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
    Serra-Burriel M; Graupera I; Torán P; Thiele M; Roulot D; Wai-Sun Wong V; Neil Guha I; Fabrellas N; Arslanow A; Expósito C; Hernández R; Lai-Hung Wong G; Harman D; Darwish Murad S; Krag A; Pera G; Angeli P; Galle P; Aithal GP; Caballeria L; Castera L; Ginès P; Lammert F;
    J Hepatol; 2019 Dec; 71(6):1141-1151. PubMed ID: 31470067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stiffness measurement by transient elastography in clinical practice.
    Sporea I; Sirli R; Deleanu A; Popescu A; Cornianu M
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):395-9. PubMed ID: 19104699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease.
    Xu N; Xie Q; Li J; Gao Y; Li X
    J Int Med Res; 2020 Feb; 48(2):300060520903667. PubMed ID: 32070159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.
    Herrmann E; de Lédinghen V; Cassinotto C; Chu WC; Leung VY; Ferraioli G; Filice C; Castera L; Vilgrain V; Ronot M; Dumortier J; Guibal A; Pol S; Trebicka J; Jansen C; Strassburg C; Zheng R; Zheng J; Francque S; Vanwolleghem T; Vonghia L; Manesis EK; Zoumpoulis P; Sporea I; Thiele M; Krag A; Cohen-Bacrie C; Criton A; Gay J; Deffieux T; Friedrich-Rust M
    Hepatology; 2018 Jan; 67(1):260-272. PubMed ID: 28370257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.